Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)

SHE:003020 Revenue

Hefei Lifeon Pharmaceutical had revenue of 301.80M CNY in the quarter ending September 30, 2026, a decrease of -13.34%. This brings the company's total for the last twelve months to 1.46B, down -1.01% year-over-year. In the year 2025, Hefei Lifeon Pharmaceutical had annual revenue of 1.55B with 2.33% growth. That makes Hefei Lifeon Pharmaceutical the 16,853rd largest company in the world by revenue and 3,059th in China.

• Revenue (ttm): 1.46B
• Revenue Growth: -1.01%
• P/S Ratio: 2.40
• Revenue / Employee: 996.02K
• Employees: 1,465
• Market Cap: 3.51B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Industry 1.40B 90.2%
• Pharmaceutical Retail 113.28M 7.3%
• Unallocated Other Business Income 38.44M 2.5%

By Geography

Chart

• China 1.55B 99.8%
• Overseas 2.55M 0.2%

Fiscal year ended Dec 31, 2025 See the full SHE:003020 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.55B	35.32M	2.33%
Dec 31, 2024	1.52B	-382.30M	-20.11%
Dec 31, 2023	1.90B	-678.55M	-26.31%
Jan 1, 2023	2.58B	306.09M	13.46%
Dec 31, 2021	2.27B	378.96M	20.01%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error